Viewing Study NCT05522556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-05-20 @ 10:20 PM
Study NCT ID: NCT05522556
Status: AVAILABLE
Last Update Posted: 2025-11-18
First Post: 2022-08-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alopecia Areata View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alopecia Areata (AA) View
None Alopecia View
None Patchy AA View
None Alopecia Universalis (AU) View
None Alopecia Totalis (AT) View
None Ophiasis View
None Eyelash Loss View
None Eyebrow Loss View
None Hair Loss View